Obatala Sciences Closes $3 Million Series A Funding Round Co-led by être Venture Capital and Ochsner Health - read this article along with other careers information, tips and advice on BioSpace
-Funding accelerates commercialization of research-enabling solutions to speed up therapies for obesity, diabetes, and cancer across diverse populations Obatala Sciences’ solutions provide research scientists in pharmaceutical companies, biotech, academia, and government laboratories with models that more accurat.